Excited to share our latest publication about the cost-effectiveness threshold in Greece.
To the best of our knowledge, this is the first study that investigated the use of cost-effectiveness threshold for evaluating pharmacological interventions in Greek pharmacoeconomic research.
The rigorous evaluation of the cost-effectiveness of interventions to prioritize resource allocation is critical to make innovative drugs available and affordable as well as to enhance evidence-based decision-making and efficiency of the healthcare system.
Hence, it is is a matter of great importance all relevant local stakeholders to initiate discussion around the appropriate level and methodology of cost-effectiveness threshold that should be used here in Greece.
Find out more at Value in Health Regional Issues